Document is current
Any future updates will be listed below
-
Authors
Mendieta, Maria Jose
Goderis, Geert
Zeller, Andreas
Yip, Olivia
Siqeca, Flaka
Zúñiga, Franziska
Zullig, Leah L.
De Geest, Sabina M. http://orcid.org/0000-0001-6596-7237
Deschodt, Mieke
Flamaing, Johan
Dhaini, Suzanne
,
Urfer, Pia
Briel, Matthias
Schwenkglenks, Matthias
Vounatsou, Penelope
Quinto, Carlos
Blozik, Eva
Obas, Katrina
-
Funding
Funding for this research was provided by:
Velux Stiftung (1167)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (183427)
Horizon 2020 (812656)
University of Basel
- License Information
-
More Information
Article History
Received: 20 June 2023
Accepted: 16 June 2024
First Online: 26 June 2024
Declarations
:
: Prior to conducting the INSPIRE feasibility study, the ethical approval was requested to the Ethics Commission Northwestern and Central Switzerland (Ethikkommission Nordwest- und Zentralschweiz – EKNZ). The EKNZ declared that the study was not subject to cantonal and federal legislation, as it was not considered a research study as defined by the Human Research Act Art. 2. Therefore, the EKNZ did not issue a formal ethical approval but concluded that the study did meet the general ethical principles for research involving human beings (cf. Art. 51 para. 2 Human Research Act). The methods used in this study were carried out in accordance with relevant guidelines and regulations. As the data collected comes from the administrative data of the IAC, no informed consent was obtained.
: Not applicable.
: The authors declare no competing interests. OY has subsequently become an employee of Novartis Pharmaceuticals Canada. However, Novartis had no involvement in the current study.
